Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

Clinical trial NCT06036784 · COMPLETED

Trial details

NCT number: NCT06036784
Sponsor: MBX Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Postbariatric Hypoglycemia

Start date: 2023-09-18
Primary completion: 2024-11-14
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.